Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Redhill Biopharma - 12 Year Stock Price History | RDHL

Historical daily share price chart and data for Redhill Biopharma since 2013 adjusted for splits and dividends. The latest closing stock price for Redhill Biopharma as of November 11, 2025 is 1.02.
  • The all-time high Redhill Biopharma stock closing price was 19790.00 on June 16, 2015.
  • The Redhill Biopharma 52-week high stock price is 8.75, which is 757.8% above the current share price.
  • The Redhill Biopharma 52-week low stock price is 1.02, which is 0% below the current share price.
  • The average Redhill Biopharma stock price for the last 52 weeks is 3.17.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Redhill Biopharma Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 2.5811 6.4000 6.6384 1.0200 1.0200 -83.57%
2024 11.5301 36.5000 37.5000 6.2100 6.2100 -82.99%
2023 72.8278 177.0000 259.0000 7.6625 36.5000 -73.98%
2022 1255.4606 2780.0000 3120.0000 137.8000 140.3000 -94.56%
2021 6494.1865 8170.0000 11290.0000 2310.0000 2580.0000 -68.07%
2020 7289.4071 6060.0000 10830.0000 3510.0000 8080.0000 33.11%
2019 7311.5103 6150.0000 9000.0000 5760.0000 6070.0000 9.37%
2018 6988.3506 5130.0000 11350.0000 4820.0000 5550.0000 7.98%
2017 8802.5478 10400.0000 10880.0000 4580.0000 5140.0000 -50.86%
2016 12017.4532 12220.0000 16290.0000 8210.0000 10460.0000 -18.79%
2015 14329.1429 13790.0000 19790.0000 11050.0000 12880.0000 -3.38%
2014 13487.5534 12379.9000 19200.0000 8030.0000 13330.0000 12.97%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.004B $0.008B
RedHill Biopharma Ltd. is a specialty biopharmaceutical company, focused on gastrointestinal and infectious diseases. It operates through the Commercial Operations segment and the Research & Development segment. The Commercial Operations segment is based in Raleigh, NC, and covers all areas relating to the commercial sales and operating expenses directly related to that activity and is being performed by the Company's subsidiary in the United States. The Research & Development segment includes all activities related to the research and development of therapeutic candidates. The company was founded in 2009 and is headquartered in Tel Aviv, Israel.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $78.129B 29.67
Zoetis (ZTS) United States $52.791B 18.89
Takeda Pharmaceutical (TAK) Japan $43.625B 8.90
Daiichi Sankyo, - (DSNKY) Japan $40.634B 20.24
BeOne Medicines - (ONC) Switzerland $36.101B 191.40
Sandoz Group AG (SDZNY) Switzerland $29.630B 0.00
United Therapeutics (UTHR) United States $19.545B 17.20
Merck (MKKGY) Germany $16.472B 10.71
Neurocrine Biosciences (NBIX) United States $14.958B 35.89
Shionogi (SGIOY) Japan $14.547B 13.36
Summit Therapeutics (SMMT) United States $14.112B 0.00
IPSEN (IPSEY) France $12.438B 0.00
Ionis Pharmaceuticals (IONS) United States $11.264B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.262B 0.00
Orion OYJ (ORINY) Finland $8.719B 24.91
Eisai (ESAIY) $8.283B 0.00
Corcept Therapeutics (CORT) United States $7.941B 85.78
Stevanato Group S.p.A (STVN) Italy $7.344B 41.10
Grifols, S.A (GRFS) Spain $5.913B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.730B 17.43
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.546B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.389B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.933B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.606B 17.13
Centessa Pharmaceuticals (CNTA) United Kingdom $2.990B 0.00
Hypermarcas (HYPMY) Brazil $2.983B 22.43
Procaps Group, S.A (PROCF) Luxembourg $2.926B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.650B 8.45
Dyne Therapeutics (DYN) United States $2.644B 0.00
Soleno Therapeutics (SLNO) United States $2.487B 0.00
Ocular Therapeutix (OCUL) United States $2.307B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.963B 23.27
Guardian Pharmacy Services (GRDN) United States $1.884B 36.28
Avadel Pharmaceuticals (AVDL) Ireland $1.816B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.516B 90.00
Collegium Pharmaceutical (COLL) United States $1.376B 6.81
Ardelyx (ARDX) United States $1.373B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.338B 0.00
Xeris Biopharma Holdings (XERS) United States $1.281B 0.00
Harrow (HROW) United States $1.263B 77.59
Nektar Therapeutics (NKTR) United States $1.179B 0.00
Oruka Therapeutics (ORKA) United States $1.161B 0.00
Enliven Therapeutics (ELVN) United States $1.108B 0.00
Relay Therapeutics (RLAY) United States $1.069B 0.00
Evotec AG (EVO) Germany $1.062B 0.00
Xencor (XNCR) United States $0.981B 0.00
Cronos Group (CRON) Canada $0.980B 0.00
ARS Pharmaceuticals (SPRY) United States $0.878B 0.00
Organogenesis (ORGO) United States $0.830B 0.00
ProKidney (PROK) United States $0.795B 0.00
Theravance Biopharma (TBPH) United States $0.759B 32.08
Savara (SVRA) United States $0.691B 0.00
Esperion Therapeutics (ESPR) United States $0.689B 0.00
Aquestive Therapeutics (AQST) United States $0.681B 0.00
Elite Pharmaceuticals (ELTP) United States $0.680B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.627B 5.60
Bioventus (BVS) United States $0.619B 12.69
KalVista Pharmaceuticals (KALV) United States $0.550B 0.00
Zevra Therapeutics (ZVRA) United States $0.512B 0.00
4D Molecular Therapeutics (FDMT) United States $0.475B 0.00
Siga Technologies (SIGA) United States $0.466B 6.38
Lexeo Therapeutics (LXEO) United States $0.460B 0.00
Altimmune (ALT) United States $0.445B 0.00
Akebia Therapeutics (AKBA) United States $0.443B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.411B 9.73
USANA Health Sciences (USNA) United States $0.351B 9.79
Nature's Sunshine Products (NATR) United States $0.346B 20.60
Lyell Immunopharma (LYEL) United States $0.340B 0.00
Galectin Therapeutics (GALT) United States $0.335B 0.00
Aldeyra Therapeutics (ALDX) United States $0.309B 0.00
Korro Bio (KRRO) United States $0.306B 0.00
Pyxis Oncology (PYXS) United States $0.297B 0.00
Larimar Therapeutics (LRMR) United States $0.294B 0.00
Achieve Life Sciences (ACHV) Canada $0.237B 0.00
Journey Medical (DERM) United States $0.235B 0.00
Aclaris Therapeutics (ACRS) United States $0.231B 0.00
OmniAb (OABI) United States $0.214B 0.00
AleAnna (ANNA) United States $0.214B 0.00
Heron Therapeutics (HRTX) United States $0.204B 0.00
Avalo Therapeutics (AVTX) United States $0.200B 0.00
MediWound (MDWD) Israel $0.199B 0.00
Profound Medical (PROF) Canada $0.181B 0.00
Protara Therapeutics (TARA) United States $0.175B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
China SXT Pharmaceuticals (SXTC) China $0.165B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.148B 0.00
Cassava Sciences (SAVA) United States $0.146B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.128B 0.00
Incannex Healthcare (IXHL) Australia $0.126B 0.00
Avita Medical (RCEL) United States $0.121B 0.00
Inhibikase Therapeutics (IKT) United States $0.118B 0.00
Context Therapeutics (CNTX) United States $0.110B 0.00
Cardiol Therapeutics (CRDL) Canada $0.104B 0.00
Surrozen (SRZN) United States $0.101B 0.00
Relmada Therapeutics (RLMD) United States $0.100B 0.00
Vivani Medical (VANI) United States $0.096B 0.00
Champions Oncology (CSBR) United States $0.093B 33.90
Karyopharm Therapeutics (KPTI) United States $0.093B 0.00
VAXART, INC (VXRT) United States $0.091B 0.00
Gain Therapeutics (GANX) United States $0.090B 0.00
Unicycive Therapeutics (UNCY) United States $0.083B 0.00
Metagenomi (MGX) United States $0.081B 0.00
Lite Strategy (LITS) United States $0.081B 0.00
Dominari Holdings (DOMH) United States $0.080B 0.00
Assertio Holdings (ASRT) United States $0.077B 0.00
Plus Therapeutics (PSTV) United States $0.077B 0.00
Nutriband (NTRB) United States $0.072B 0.00
Prelude Therapeutics (PRLD) United States $0.071B 0.00
PMV Pharmaceuticals (PMVP) United States $0.069B 0.00
Rafael Holdings (RFL) United States $0.067B 0.00
Acrivon Therapeutics (ACRV) United States $0.064B 0.00
BioNxt Solutions (BNXTF) Canada $0.062B 0.00
PolyPid (PYPD) Israel $0.059B 0.00
Talphera (TLPH) United States $0.059B 0.00
Fractyl Health (GUTS) United States $0.056B 0.00
Wellgistics Health (WGRX) United States $0.053B 0.00
NRx Pharmaceuticals (NRXP) United States $0.050B 0.00
ElectroCore (ECOR) United States $0.050B 0.00
Jupiter Neurosciences (JUNS) United States $0.048B 0.00
Century Therapeutics (IPSC) United States $0.047B 0.00
FibroGen (FGEN) United States $0.044B 0.00
Telomir Pharmaceuticals (TELO) United States $0.044B 0.00
Tempest Therapeutics (TPST) United States $0.043B 0.00
Klotho Neurosciences (KLTO) United States $0.039B 0.00
Inotiv (NOTV) United States $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Liminatus Pharma (LIMN) United States $0.032B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.030B 24.75
Iterum Therapeutics (ITRM) Ireland $0.029B 0.00
Cosmos Health (COSM) United States $0.025B 0.00
SCYNEXIS (SCYX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Scienture Holdings (SCNX) United States $0.024B 0.00
Mangoceuticals (MGRX) United States $0.022B 0.00
Citius Pharmaceuticals (CTXR) United States $0.022B 0.00
Vyome Holdings (HIND) United States $0.020B 0.00
Heatwurx (PCSA) United States $0.020B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Natural Alternatives (NAII) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.015B 0.00
Traws Pharma (TRAW) United States $0.014B 0.02
Ainos (AIMD) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
BioVie (BIVI) United States $0.012B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
VYNE Therapeutics (VYNE) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
CDT Equity (CDT) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 15.76
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00